CLLEAR RX LTD

Executive Summary

Cllear RX Ltd exhibits a low financial risk profile with improving liquidity, net assets, and compliance standing. Despite this, the disclosed going concern material uncertainties and reliance on a single director warrant further examination to confirm operational resilience. Overall, the company appears solvent and compliant based on the latest filed accounts and statutory returns.

View Full Analysis Report →
Legal registered address
167-169 Great Portland Street 5th Floor London England W1W 5PF Copied!

Latest financial results as of 12 September 2025
Cash in bank
£20.32k
Current assets
£46.95k
Fixed assets
£3.43k
Current creditors
£14.80k
Shareholders funds
£34.71k
View full financial accounts

Company number
13123964 Copied!
Company status
Active
Company type
Private Limited Company
Accounts category
Total Exemption Full
Incorporated on
11 January 2021
Accounts

Latest annual accounts were to 31 January 2024

Next annual accounts are due by 31 October 2025

Company financial year end is on 31 January 2026

Confirmation statement

Latest confirmation statement statement dated 10 January 2025

Next statement due by 24 January 2026

View original and historic source data
Nature of business (SIC)

26701 - Manufacture of optical precision instruments

Latest company documents
DateDescription
21/01/2521 January 2025 Confirmation statement made on 2025-01-10 with no updates

View Document

29/10/2429 October 2024 Total exemption full accounts made up to 2024-01-31

View Document

31/01/2431 January 2024 Annual accounts for year ending 31 Jan 2024

View Accounts

18/01/2418 January 2024 Confirmation statement made on 2024-01-10 with no updates

View Document

31/10/2331 October 2023 Total exemption full accounts made up to 2023-01-31

View Document

View all company documents

More Company Information


Follow Company
  • Receive an alert email on changes to financial status
  • Early indications of liquidity problems
  • Warns when company reporting is overdue
  • Free service, no spam emails
  • Follow this company